Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome

被引:52
|
作者
Allen, RP
Mignot, E
Ripley, B
Nishino, S
Earley, CJ
机构
[1] Stanford Univ, Ctr Narcolepsy, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA
关键词
D O I
10.1212/WNL.59.4.639
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hypocretin-1 levels were increased in evening CSF samples from subjects with restless legs syndrome, indicating altered hypocretin transmission in this sleep disorder. Increases in CSF hypocretin-1 levels were most striking in patients with early-onset restless legs syndrome.
引用
收藏
页码:639 / 641
页数:3
相关论文
共 50 条
  • [21] Decreased CSF hypocretin-1 (orexin-A) in patients after acute haemorrhagic brain stroke
    Rejdak, K
    Petzold, A
    Lin, L
    Smith, M
    Kitchen, N
    Grieb, P
    Stelmasiak, Z
    Thompson, EJ
    JOURNAL OF NEUROLOGY, 2005, 252 : 8 - 8
  • [22] Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1)
    Calva, Coleman B.
    Fayyaz, Habiba
    Fadel, Jim R.
    JOURNAL OF NEUROCHEMISTRY, 2018, 145 (03) : 232 - 244
  • [23] Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers
    John, J
    Wu, MF
    Maidment, NT
    Lam, HA
    Boehmer, LN
    Patton, M
    Siegel, JM
    JOURNAL OF PHYSIOLOGY-LONDON, 2004, 560 (02): : 587 - 592
  • [24] Hypocretin-1/orexin-A activates subfornical organ neurons of rats
    Ono, Kentaro
    Kai, Aya
    Honda, Eiko
    Inenaga, Kiyotoshi
    NEUROREPORT, 2008, 19 (01) : 69 - 73
  • [25] CSF hypocretin-1 (orexin-A) concentration of patients with Niemann-Pick type C disease.
    Abe, M
    Kanbayashi, T
    Fujimoto, S
    Takahashi, T
    Takemura, T
    Suzuki, F
    Tashiro, T
    Iijima, S
    Hishikawa, Y
    Shimizu, T
    SLEEP, 2002, 25 : A376 - A377
  • [26] Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis
    Yasunori Oka
    Takashi Kanbayashi
    Takahiro Mezaki
    Kazumi Iseki
    Jun Matsubayashi
    Gaku Murakami
    Masaru Matsui
    Tetsuo Shimizu
    Hiroshi Shibasaki
    Journal of Neurology, 2004, 251 : 885 - 886
  • [27] Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis
    Oka, Y
    Kanbayashi, T
    Mezaki, T
    Iseki, K
    Matsubayashi, J
    Murakami, G
    Matsui, M
    Shimizu, T
    Shibasaki, H
    JOURNAL OF NEUROLOGY, 2004, 251 (07) : 885 - 886
  • [28] Hypocretin-1 (Orexin-A) levels in human lumbar CSF in different age groups: Infants to elderly persons
    Kanbayashi, T
    Yano, T
    Ishiguro, H
    Kawanishi, K
    Chiba, S
    Aizawa, R
    Sawaishi, Y
    Hirota, K
    Nishino, S
    Shimizu, T
    SLEEP, 2002, 25 (03): : 337 - 339
  • [29] Intranasal Drug Targeting of Hypocretin-1 (Orexin-A) to the Central Nervous System
    Dhuria, Shyeilla V.
    Hanson, Leah R.
    Frey, William H., II
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (07) : 2501 - 2515
  • [30] Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding
    Sweet, DC
    Levine, AS
    Kotz, CM
    PEPTIDES, 2004, 25 (02) : 307 - 314